S. Pöhlmann

Journal of Virology · 2005–2021

A researcher in the Science corpus: 8 papers; trusts 0 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Who trusts S. Pöhlmann overall

1. M. Hoffmann

Papers from S. Pöhlmann's perspective

Ordered by how strongly the researchers S. Pöhlmann trusts endorse each paper. Same corpus, a different order for every researcher.

1. What’s new in the renin-angiotensin system?
2. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites (Proceedings of the National Academy of Sciences of the United States of America)
3. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury (Nature Medicine)
4. A pneumonia outbreak associated with a new coronavirus of probable bat origin
5. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis (Journal of Pathology)
6. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry (Proceedings of the National Academy of Sciences of the United States of America)
7. Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor (Science)
8. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin)
9. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (Science)
10. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. (Proceedings of the National Academy of Sciences of the United States of America)

Their papers

• SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) — 864 citations
• The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic (2021) — 838 citations
• A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells (2020) — 1,708 citations
• The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells (2020) — 742 citations
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (2020) — 18,267 citations
• TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein (2013) — 824 citations
• Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response (2011) — 974 citations
• Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry (2005) — 803 citations